The NPF welcomes this new and relatively brief HESA report as valuable background information as we advocate for National Pharmacare, and better control over rising drug prices.
The NPF welcomes this new and relatively brief HESA report as valuable background information as we advocate for National Pharmacare, and better control over rising drug prices.